Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Medtronic Receives FDA Approval for Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator

      Medtronic Receives FDA Approval for Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator

      supriya kashyap kashyap17 Nov 2016 2:02 PM IST
      Dublin : Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI(TM) Quad Cardiac Resynchronization Therapy...
      Sanofi India MD Ayyangar gets French civil distinction

      Sanofi India MD Ayyangar gets French civil distinction

      supriya kashyap kashyap17 Nov 2016 1:58 PM IST
      Mumbai : Sanofi Managing Director India and Vice-President, South Asia, Shailesh Ayyangar, was conferred the French civil distinction, officier de...
      Trivitron Healthcare hosts Symposium on HbA1c Measurement

      Trivitron Healthcare hosts Symposium on HbA1c Measurement

      supriya kashyap kashyap17 Nov 2016 9:00 AM IST
      New Delhi : Trivitron Healthcare, the largest medical technology company of Indian origin, in association with Sebia hosted a Symposium on the...
      Myelofibrosis market will exceed $1 billion by 2025, says GlobalData

      Myelofibrosis market will exceed $1 billion by 2025, says GlobalData

      supriya kashyap kashyap16 Nov 2016 12:52 PM IST
      London : The myelofibrosis market is expected to almost double in value from $545.2 million in 2015 to $1.02 billion by 2025, representing a compound...
      Lupin launches Amabelz tablets in US market

      Lupin launches Amabelz tablets in US market

      supriya kashyap kashyap16 Nov 2016 12:49 PM IST
      New Delhi : Drug major Lupin said it has launched Amabelz tablets, used in prevention of postmenopausal osteoporosis, in the American market after...
      Pricing pressure on Indian drug companies to continue: Fitch Ratings

      Pricing pressure on Indian drug companies to continue: Fitch Ratings

      supriya kashyap kashyap16 Nov 2016 12:48 PM IST
      Chennai : Indian pharmaceutical industry will face pricing pressure in the US and domestic markets for some more time to come and the players have to...
      Sun Pharma, others ink pact for malaria project in Mandla

      Sun Pharma, others ink pact for malaria project in Mandla

      supriya kashyap kashyap16 Nov 2016 12:46 PM IST
      New Delhi : Drug major Sun Pharma announced signing of tri-party agreement between Indian Council of Medical Research, Government of Madhya Pradesh...
      Bariatric surgery market for diabetes estimated at Rs 200 crores

      Bariatric surgery market for diabetes estimated at Rs 200 crores

      supriya kashyap kashyap16 Nov 2016 12:43 PM IST
      Mumbai : With India having 64.5 million patients of diabetes, a number expected to grow in the coming years, the bariatric surgery market is estimated...
      Novartis leukemia drug wins FDA priority review

      Novartis leukemia drug wins FDA priority review

      supriya kashyap kashyap15 Nov 2016 5:17 PM IST
      Novartis's investigational drug PKC 412 won U.S. Food and Drug Administration priority review, the Swiss drug maker said, keeping up momentum after...
      Apollo plans to invest Rs 1400 cr to expand business, launch Proton therapy Facility

      Apollo plans to invest Rs 1400 cr to expand business, launch Proton therapy Facility

      supriya kashyap kashyap15 Nov 2016 1:34 PM IST
      Mumbai : Healthcare group Apollo Hospitals has plans to invest Rs 1,400 crore over the next couple of years for expansion, a top company official...
      FDA rejects Dynavax hepatitis B vaccine

      FDA rejects Dynavax hepatitis B vaccine

      supriya kashyap kashyap15 Nov 2016 1:31 PM IST
      The U.S. Food and Drug Administration rejected Dynavax Technologies Corp's hepatitis B vaccine for the second time in three years, casting doubts on...
      J&J arthritis drug goes up against Humira, with mixed results

      J&J arthritis drug goes up against Humira, with mixed results

      supriya kashyap kashyap15 Nov 2016 9:26 AM IST
      Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok